What Is the Relationship Between the Liver and Lung Cancer?

Liver metastasis: The liver is also a common metastatic site for lung cancer. About 28-33% of lung cancers develop liver metastases. Liver metastases are cancers of the primary lung cancer that fall off and invade the liver through the blood circulation and grow in the liver.

Lung cancer liver metastasis

Liver metastasis: The liver is also a common metastatic site for lung cancer. About 28-33% of lung cancers develop liver metastases. Liver metastases are

Liver metastasis: The liver is also a common metastatic site for lung cancer, with liver metastasis occurring in approximately 28-33% of lung cancers. Liver metastases are

The most common symptom is persistent pain in the liver area, which can be accompanied by impaired appetite, indigestion, and other symptoms of impaired liver function. The liver is also one of the most common metastatic sites in lung cancer.

Tumor typing comprehensive treatment system

Indications for comprehensive treatment include most tumors, such as liver cancer, stomach cancer, lung cancer, esophageal cancer, nasopharyngeal cancer, hemangioma, metastases, gliomas, meningiomas, intracranial aneurysms, lung adenocarcinomas, intrathoracic Cancer, lung squamous cell carcinoma, mediastinal tumor, breast cancer, cholangiomas, hepatic hemangioma, liver cysts, colorectal cancer, colon cancer, cardiac cancer, rectal cancer, transitional cell cancer, pancreatic cancer, spleen rupture, islet cell tumor, spleen Aneurysms and so on.

The treatment of liver metastases from lung cancer is mainly to alleviate the suffering of patients and prolong their lives.

Clinical studies have shown that when DC-CIK is mixed culture, the two can regulate each other to increase cytokine release and enhance cytotoxicity. The combined application will achieve a "1 + 1> 2" curative effect and significantly increase the proliferation and killing activity of CIK cells. And stimulate the body's specific anti-tumor immunity to achieve long-term control and killing effect on tumor cells. At present, the new clinical development of immune cells in treating tumors at home and abroad is the combined application of DC-CIK cells, which is the best combination method for cellular immunotherapy of tumors.

Chemotherapy

Systemic chemotherapy can also control the development of bone metastases and relieve pain while treating the primary lesions in the lungs. Therefore, it can not only relieve pain, but also kill cancer cells and control their growth, especially with large doses of cisplatin The main combination chemotherapy regimen is more effective. In some cases, the bone metastases disappeared and a new cortical bone was formed when the x-ray film was reviewed. Since bone metastases in lung cancer cases may have potential micrometastases in other organs in the body, combined systemic chemotherapy also treats bone metastases at the same time as other potential metastases. There is also zoledronic acid, which is mainly targeted at bone metastases.

Radiation Therapy

Radiation therapy can be divided into several methods such as 60 cobalt irradiation, deep x-ray machine and linear accelerator. After the lung lesions are controlled and stabilized by chemotherapy, large doses and short courses of radiation therapy can be given to relieve pain, kill cancer cells, and control the development of the lesions. About 50% of patients have complete pain relief after radiation therapy, and about 75% of patients have significant pain relief.

Radiation therapy has developed rapidly, improving the accuracy of treatment, reducing the side effects of treatment, and adding new hope to patients who cannot be treated surgically. China's more advanced radiation therapy is the radio knife treatment. It continues to develop on the basis of the original radiotherapy, and improves the original shortcomings of the original radiotherapy equipment, such as the introduction of synchronous breathing system, increased asymmetric center and non-coplanar principle, which greatly reduces the time of radiotherapy and the accuracy of treatment Increase, and achieve no anesthesia, no hospitalization.

Biological immunotherapy

The conventional treatment methods used clinically cannot be completely removed or completely killed by surgery, radiotherapy and chemotherapy, and tumor metastasis or recurrence often occurs. Biological therapy of tumors is the fourth mode of tumor therapy because of its safety, effectiveness, and low adverse reactions. At present, the most commonly used biological treatment methods are immunotherapy, gene therapy, anti-angiogenesis therapy, oncolytic virus therapy, stem cell therapy, induced differentiation and apoptosis, and endocrine therapy. ^[1]

Biological immunotherapy is an emerging tumor treatment model with significant curative effect, and it is a new type of autoimmune anti-cancer treatment. It is a method of using biotechnology and biologics to culture and expand immune cells (DC and CIK cells) collected from a patient in vitro and return them to the patient to stimulate and enhance the body's autoimmune function, thereby achieving the treatment of tumors. The purpose is to be the fourth largest treatment method in addition to surgery, radiotherapy and chemotherapy.

Targeted therapy

Radionuclide internal radiation therapy is actually a targeted therapy for lung cancer bone metastases.

For patients with systemic multiple bone metastases, radiotherapy is not appropriate, and radionuclide treatment can be taken at this time. The radionuclide can reduce bone destruction and dissolution caused by bone metastases, and can eliminate or alleviate severe pain caused by bone metastases, while inhibiting the development of bone metastases. However, because it can also cause a bone marrow suppression response, it is not used in combination with chemotherapy in principle, and white blood cell changes must be observed regularly.

Lung cancer bone metastases also need to be treated in conjunction with the symptoms of lung cancer. Lung cancer is mainly divided into two categories, one is small cell lung cancer, and the other is non-small cell lung cancer. Small cell lung cancer cannot use targeted therapy; non-small cell lung cancer includes squamous cell carcinoma, adenocarcinoma, squamous adenocarcinoma, and large cell carcinoma.